PDB Short entry for 5M4I HEADER TRANSFERASE 18-OCT-16 5M4I TITLE COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH TITLE 2 THE INHIBITOR 4'-CARBOXY-6,8-CHLORO-FLAVONOL (FLC21) CRYSTALLIZED TITLE 3 UNDER HIGH-SALT CONDITIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,N.BISCHOFF,S.M.YARMOLUK,V.G.BDZHOLA,A.G.GOLUB,A.O.BALANDA, AUTHOR 2 A.O.PRYKHOD'KO REVDAT 6 17-JAN-24 5M4I 1 REMARK REVDAT 5 06-SEP-17 5M4I 1 ATOM REVDAT 4 17-MAY-17 5M4I 1 JRNL REVDAT 3 10-MAY-17 5M4I 1 JRNL REVDAT 2 25-JAN-17 5M4I 1 JRNL REVDAT 1 18-JAN-17 5M4I 0 JRNL AUTH K.NIEFIND,N.BISCHOFF,A.G.GOLUB,V.G.BDZHOLA,A.O.BALANDA, JRNL AUTH 2 A.O.PRYKHOD'KO,S.M.YARMOLUK JRNL TITL STRUCTURAL HYPERVARIABILITY OF THE TWO HUMAN PROTEIN KINASE JRNL TITL 2 CK2 CATALYTIC SUBUNIT PARALOGS REVEALED BY COMPLEX JRNL TITL 3 STRUCTURES WITH A FLAVONOL- AND A JRNL TITL 4 THIENO[2,3-D]PYRIMIDINE-BASED INHIBITOR. JRNL REF PHARMACEUTICALS V. 10 2017 JRNL REFN ESSN 1424-8247 JRNL PMID 28085026 JRNL DOI 10.3390/PH10010009 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.GUERRA,N.BISCHOFF,V.G.BDZHOLA,S.M.YARMOLUK,O.G.ISSINGER, REMARK 1 AUTH 2 A.G.GOLUB,K.NIEFIND REMARK 1 TITL A NOTE OF CAUTION ON THE ROLE OF HALOGEN BONDS FOR PROTEIN REMARK 1 TITL 2 KINASE/INHIBITOR RECOGNITION SUGGESTED BY HIGH- AND LOW-SALT REMARK 1 TITL 3 CK2ALPHA COMPLEX STRUCTURES. REMARK 1 REF ACS CHEM. BIOL. V. 10 1654 2015 REMARK 1 REFN ESSN 1554-8937 REMARK 1 PMID 25961323 REMARK 1 DOI 10.1021/ACSCHEMBIO.5B00235 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,N.V.BRIUKHOVETSKA,A.O.BALANDA, REMARK 1 AUTH 2 O.P.KUKHARENKO,I.M.KOTEY,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED REMARK 1 TITL 2 (THIENO[2,3-D]PYRIMIDIN-4-YLTHIO)CARBOXYLIC ACIDS AS REMARK 1 TITL 3 INHIBITORS OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF EUR J MED CHEM V. 46 870 2011 REMARK 1 REFN ISSN 1768-3254 REMARK 1 PMID 21276643 REMARK 1 DOI 10.1016/J.EJMECH.2010.12.025 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,Y.V.KYSHENIA,V.M.SAPELKIN, REMARK 1 AUTH 2 A.O.PRYKHOD'KO,O.P.KUKHARENKO,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL STRUCTURE-BASED DISCOVERY OF NOVEL FLAVONOL INHIBITORS OF REMARK 1 TITL 2 HUMAN PROTEIN KINASE CK2. REMARK 1 REF MOL. CELL. BIOCHEM. V. 356 107 2011 REMARK 1 REFN ISSN 1573-4919 REMARK 1 PMID 21735097 REMARK 1 DOI 10.1007/S11010-011-0945-8 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.09 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 18348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.640 REMARK 3 FREE R VALUE TEST SET COUNT : 1034 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.0972 - 4.2424 1.00 2633 176 0.1698 0.2056 REMARK 3 2 4.2424 - 3.3675 1.00 2506 142 0.1571 0.1914 REMARK 3 3 3.3675 - 2.9419 1.00 2453 150 0.1967 0.2326 REMARK 3 4 2.9419 - 2.6730 1.00 2457 136 0.2179 0.2718 REMARK 3 5 2.6730 - 2.4814 1.00 2435 140 0.2258 0.2742 REMARK 3 6 2.4814 - 2.3351 1.00 2403 145 0.2245 0.3034 REMARK 3 7 2.3351 - 2.2181 1.00 2427 145 0.2555 0.3015 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2898 REMARK 3 ANGLE : 0.465 3922 REMARK 3 CHIRALITY : 0.042 403 REMARK 3 PLANARITY : 0.003 504 REMARK 3 DIHEDRAL : 20.122 1730 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 3 THROUGH 108 ) REMARK 3 ORIGIN FOR THE GROUP (A): -22.6965 2.7655 30.0114 REMARK 3 T TENSOR REMARK 3 T11: 0.3991 T22: 0.3966 REMARK 3 T33: 0.3176 T12: 0.0372 REMARK 3 T13: -0.0076 T23: -0.0378 REMARK 3 L TENSOR REMARK 3 L11: 1.6301 L22: 3.5005 REMARK 3 L33: 4.2180 L12: -0.3962 REMARK 3 L13: 0.5281 L23: -1.7721 REMARK 3 S TENSOR REMARK 3 S11: -0.0753 S12: -0.1728 S13: 0.0369 REMARK 3 S21: 0.0126 S22: 0.0705 S23: 0.3356 REMARK 3 S31: -0.4626 S32: -0.3351 S33: 0.0001 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 109 THROUGH 129 ) REMARK 3 ORIGIN FOR THE GROUP (A): -12.2128 1.3717 14.6706 REMARK 3 T TENSOR REMARK 3 T11: 0.6964 T22: 0.7157 REMARK 3 T33: 0.5382 T12: -0.0032 REMARK 3 T13: 0.0953 T23: 0.0393 REMARK 3 L TENSOR REMARK 3 L11: 0.8064 L22: 2.3212 REMARK 3 L33: 0.9392 L12: -1.2900 REMARK 3 L13: -0.5908 L23: 1.3070 REMARK 3 S TENSOR REMARK 3 S11: 0.0735 S12: 0.6837 S13: 0.3144 REMARK 3 S21: -1.0609 S22: 0.2226 S23: -0.5634 REMARK 3 S31: -0.2401 S32: 0.2644 S33: 0.1302 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 130 THROUGH 249 ) REMARK 3 ORIGIN FOR THE GROUP (A): -13.0160 -12.5624 22.6516 REMARK 3 T TENSOR REMARK 3 T11: 0.2544 T22: 0.3293 REMARK 3 T33: 0.3215 T12: 0.0228 REMARK 3 T13: 0.0037 T23: 0.0130 REMARK 3 L TENSOR REMARK 3 L11: 3.1479 L22: 1.3747 REMARK 3 L33: 2.5824 L12: -0.3112 REMARK 3 L13: 0.0981 L23: 1.0729 REMARK 3 S TENSOR REMARK 3 S11: 0.0685 S12: 0.2590 S13: -0.1789 REMARK 3 S21: -0.1433 S22: -0.0062 S23: -0.0659 REMARK 3 S31: -0.0721 S32: 0.0681 S33: 0.0023 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 250 THROUGH 333 ) REMARK 3 ORIGIN FOR THE GROUP (A): -5.2614 -22.6883 21.6493 REMARK 3 T TENSOR REMARK 3 T11: 0.3467 T22: 0.4402 REMARK 3 T33: 0.5342 T12: 0.0683 REMARK 3 T13: -0.0443 T23: -0.0234 REMARK 3 L TENSOR REMARK 3 L11: 3.2186 L22: 3.1830 REMARK 3 L33: 2.3691 L12: 0.1810 REMARK 3 L13: 0.6065 L23: 0.5895 REMARK 3 S TENSOR REMARK 3 S11: 0.1427 S12: 0.2143 S13: -0.8111 REMARK 3 S21: -0.0399 S22: 0.2430 S23: -0.1089 REMARK 3 S31: 0.2947 S32: 0.2889 S33: 0.0132 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5M4I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001928. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18350 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.218 REMARK 200 RESOLUTION RANGE LOW (A) : 49.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.11090 REMARK 200 R SYM (I) : 0.11090 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 0.1109 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.90 REMARK 200 R MERGE FOR SHELL (I) : 1.16900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2PVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 6 MG/ML REMARK 280 CK2ALPHA1-335 IN 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5; INHIBITOR REMARK 280 STOCK SOLUTION: 10 MM INHIBITOR IN DMSO; PROTEIN/INHIBITOR REMARK 280 COMPLEX SOLUTION: 90 MICROLITER PROTEIN STOCK SOLUTION + 10 REMARK 280 MICROLITER INHIBITOR STOCK SOLUTION; RESERVOIR SOLUTION: 4.3 M REMARK 280 NACL, 0.1 M SODIUM CITRATE, PH 5.2; DROP SOLUTION BEFORE REMARK 280 EQULIBRATION: 0.5 MICROLITER PROTEIN/INHIBITOR COMPLEX SOLUTION + REMARK 280 0.5 MICROLITER RESERVOIR SOLUTION, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.62600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.29550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.29550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 99.93900 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.29550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.29550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.31300 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.29550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.29550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 99.93900 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.29550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.29550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 33.31300 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 66.62600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 590 O HOH A 602 1.87 REMARK 500 O HOH A 579 O HOH A 591 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 156 44.45 -152.67 REMARK 500 ASP A 175 71.81 56.20 REMARK 500 ALA A 193 175.32 61.14 REMARK 500 MET A 208 46.43 -92.97 REMARK 500 ASP A 210 -154.42 -148.82 REMARK 500 HIS A 286 -110.02 -142.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7FC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 406 DBREF 5M4I A 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET 7FC A 401 23 HET CL A 402 1 HET CL A 403 1 HET CL A 404 1 HET CL A 405 1 HET CL A 406 1 HETNAM 7FC 4-[6,8-BIS(CHLORANYL)-3-OXIDANYL-4-OXIDANYLIDENE- HETNAM 2 7FC CHROMEN-2-YL]BENZOIC ACID HETNAM CL CHLORIDE ION FORMUL 2 7FC C16 H8 CL2 O5 FORMUL 3 CL 5(CL 1-) FORMUL 8 HOH *110(H2 O) HELIX 1 AA1 ASP A 14 ARG A 19 1 6 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 ASN A 35 ASP A 37 5 3 HELIX 4 AA4 LYS A 74 ARG A 89 1 16 HELIX 5 AA5 ASP A 120 TYR A 125 1 6 HELIX 6 AA6 THR A 129 MET A 150 1 22 HELIX 7 AA7 LYS A 158 HIS A 160 5 3 HELIX 8 AA8 SER A 194 LYS A 198 5 5 HELIX 9 AA9 GLY A 199 VAL A 204 1 6 HELIX 10 AB1 TYR A 211 ARG A 228 1 18 HELIX 11 AB2 ASP A 237 GLY A 250 1 14 HELIX 12 AB3 THR A 251 TYR A 261 1 11 HELIX 13 AB4 ASP A 266 GLY A 274 1 9 HELIX 14 AB5 ARG A 280 VAL A 285 5 6 HELIX 15 AB6 ASN A 289 VAL A 293 5 5 HELIX 16 AB7 SER A 294 LEU A 305 1 12 HELIX 17 AB8 THR A 314 GLU A 320 1 7 HELIX 18 AB9 HIS A 321 TYR A 323 5 3 HELIX 19 AC1 PHE A 324 ARG A 333 1 10 SHEET 1 AA1 5 TYR A 39 LYS A 44 0 SHEET 2 AA1 5 VAL A 53 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 AA1 5 LYS A 64 ILE A 69 -1 O VAL A 67 N PHE A 54 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O LEU A 111 N LYS A 68 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N ALA A 98 O VAL A 112 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -3.14 SITE 1 AC1 12 TYR A 50 VAL A 66 LYS A 68 ILE A 95 SITE 2 AC1 12 PHE A 113 GLU A 114 HIS A 115 VAL A 116 SITE 3 AC1 12 MET A 163 ASP A 175 HOH A 511 HOH A 512 SITE 1 AC2 3 LYS A 158 PRO A 159 HIS A 160 SITE 1 AC3 3 ARG A 155 TYR A 188 ASN A 189 SITE 1 AC4 2 HIS A 148 ALA A 315 SITE 1 AC5 4 LYS A 229 PHE A 232 HIS A 234 ARG A 244 SITE 1 AC6 4 SER A 51 LYS A 68 HIS A 160 HOH A 592 CRYST1 72.591 72.591 133.252 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013776 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013776 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007505 0.00000